Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/12/2003CN1401376A Green tea polyphenol anti-caries coating film
03/12/2003CN1401367A Ointment for intervertebral disc
03/12/2003CN1401361A Medicine for treating aphtha
03/12/2003CN1401359A Medicine for treating hand and foot tinea and ringworm of nails
03/12/2003CN1401349A Formulation of tumor treating capsule, and inspecting method thereof
03/12/2003CN1401344A Chinese medicine gel for treating cervicitis and cervical erosion, and preparing method thereof
03/12/2003CN1401336A Medicine of treating dermatosis for external use
03/12/2003CN1401328A Epidemic meningitis polyose-protein binding vaccine
03/12/2003CN1401327A Medicine for treating by-effect caused by chemotherapy and radiotherapy, and producing method thereof
03/12/2003CN1401326A Total flavone for treating cadiovasular cerebrovasular system diseases, and preparing method and use thereof
03/12/2003CN1401325A Pharmaceutical composition
03/12/2003CN1401324A Antibiotic medicine for injection
03/12/2003CN1401323A Compound ointment for treating fungous dermatosis
03/12/2003CN1401322A Concentrated clear solution contg. biocefalin as brain metabolism improving medicine for intravenous injection after diluting it
03/12/2003CN1401321A Pharmaceutic composition of anti-platelet aggregation
03/12/2003CN1401320A Medicine for treating menopausal syndrome
03/12/2003CN1401319A Use of GABA transport protein inhibitor in preparing medicine for treating alcohol habituation and abuse
03/12/2003CN1401318A Chinese traditional medicine hypoglycemic agent and preparing process thereof
03/12/2003CN1401317A Use of bismuth subgallate in suppressing formation of nitrogen oxide synthetase
03/12/2003CN1401316A Use of trans-diphenylethene derivs in preventing and treating liver fibrosis
03/12/2003CN1401257A Chewing gum component for eliminating nicotine
03/12/2003CN1102932C Novel water-soluble analogues of 20(S)-camptothecin, preparing method and use thereof
03/12/2003CN1102931C Acylated N-hydroxy methyl thalidomide prodrugs with immunomodulator action
03/12/2003CN1102927C Prepn. of 1-butyl-4-piperidinylmethylamine
03/12/2003CN1102853C Tumor metastasis suppressing agent and veterinary tumor metastasis suppressing agent
03/12/2003CN1102852C Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs
03/12/2003CN1102851C Plasma like solution
03/12/2003CN1102850C Percutaneously absorbable preparation
03/12/2003CN1102849C Use of octopirox as depigmenting agent
03/12/2003CN1102848C Chemical medicine composition for treating hypertension
03/12/2003CN1102847C Medicine or nutrient contg. daidzein material
03/12/2003CN1102831C Two and three component fungicidal mixtures
03/12/2003CA2422067A1 Aminoheterocycles (factor xa inhibitors 14)
03/11/2003WO2002022578A1 (2-azabicyclo[2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
03/11/2003US6531622 Crytalline form of (s)-2 ethoxy -3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy)phenyl]propanoic acid
03/11/2003US6531614 Converting lactone to monosilyloxy carboxaldehyde for treatment of glaucoma and ocular hypertension
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531609 Process for the preparation of thiazolidinedione derivatives
03/11/2003US6531608 Various thiol complexes, processes for their synthesis and clinical applications
03/11/2003US6531600 Treatment and compounds
03/11/2003US6531599 Compounds having activity as inhibitors of cytochrome P450RAI
03/11/2003US6531598 Naphthostyrils
03/11/2003US6531582 2-O-(9z,12z-octadecadienoyl)-3-O-[α-D-galactopyranosyl-(1″-6′)-O-α-D-galactopyranosyl]glycerol and pharmaceutical composition containing the same
03/11/2003US6531512 Method of treating cancer in patients having a deficiency in p53 tumor suppressor gene
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531510 N,N′-bis(2-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid in iron chelating therapy
03/11/2003US6531509 <.5% of a corresponding lactam and > 20 ppm of an anion of a mineral acid, and after one year of storage at 25 degrees C. and 60% humidity conversion to the lactam doesn't exceed .2%
03/11/2003US6531508 Antibacterial medicinal compositions
03/11/2003US6531507 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/11/2003US6531506 Inhibitors of epoxide hydrolases for the treatment of hypertension
03/11/2003US6531505 Flavanoids or chromones of given formula that inhibit activated T cells; used for treating autoimmune disease, inflammatory reaction, fibrosis, transplant rejection, graft versus host disease, or allergic disease
03/11/2003US6531504 Prostanoic acid derivatives as agents for lowering intraocular pressure
03/11/2003US6531503 Benzofurane derivatives
03/11/2003US6531500 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering by administering an oil-in-water emulsion comprising: (a) allantoin; and (b) an emulsifier system including beeswax and an anionic emulsifier
03/11/2003US6531498 Antiallergens, etc
03/11/2003US6531497 Epothilone derivatives and their synthesis and use
03/11/2003US6531493 3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531490 Production of agglomerates of inogatran and the compound inogatran anhydrate
03/11/2003US6531488 Method of treating neurodegenerative diseases
03/11/2003US6531484 Viricides for preventing infection by HIV, treating infection by HIV, delaying of the onset of AIDS, or treating AIDS
03/11/2003US6531482 Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation
03/11/2003US6531480 Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531478 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders
03/11/2003US6531477 Treating cancer or other proliferative diseases
03/11/2003US6531476 Piperazine derivatives inhibiting human immunodeficiency virus replication
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531473 Method of treatment using arylalkylpyridazinones
03/11/2003US6531472 Tetralone derivatives
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/11/2003US6531470 Oxazolidinone combinatorial libraries, compositions and methods of preparation
03/11/2003US6531469 Substituted 1-(4-piperidyl)-3-(aryl) isothioureas their preparation and their therapeutic application
03/11/2003US6531468 Inhibiting serotonin reuptake in the central nervous system of a mammal
03/11/2003US6531467 Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
03/11/2003US6531465 Antibacterial cephalosporins
03/11/2003US6531463 Dissolving starting material containing beta-sitosterol or beta-sitosterol and beta-sitostanol in oil and/or fat by heating, cooling mixture, adding water at same temperature, agitating to form homogeneous and stable dispersion
03/11/2003US6531462 Medicament for treating obesity and improving lipid metabolism
03/11/2003US6531461 Medicament for the treatment of diabetes
03/11/2003US6531459 Vitamin D derivatives with phosphorus atoms in the side chains
03/11/2003US6531458 Stable formulation for oral administration
03/11/2003US6531457 A2A adenosine receptor antagonists such as methyl-4-(3-(9-(5-(N-ethylcarbamoyl)-3,4-dihydrooxolan-2-yl)-6-aminopurin-2 -yl))prop-2-ynyl)cyclohexane-carboxylate
03/11/2003US6531453 Activating human NKT cell by culturing in vitro mononuclear cell fraction comprising human NKT cell in presence of specified compound or salt or solvate thereof
03/11/2003US6531452 Peptide-like and peptidomimetic compounds that inhibit enzymatic activity of picornaviral 3C proteases and inhibit picornavirus replication
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/11/2003US6531435 Compositions for the inhibition of exoprotein production from Gram positive bacteria
03/11/2003US6531313 Invasive bacterial vectors for expressing alphavirus replicons
03/11/2003US6531303 Method of producing geranylgeraniol
03/11/2003US6531291 Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
03/11/2003US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications
03/11/2003US6531162 Adrenergically-mediated weight loss product
03/11/2003US6531160 Microcapsules with an aqueous core containing at least one water-soluble cosmetic or dermatological active principle and cosmetic or dermatological compositions containing them
03/11/2003US6531157 The present invention relates to stable emulsions and dry powders of mixtures of fat-soluble vitamins, and to processes for their preparation and to their use.
03/11/2003US6531153 Composition with sustained release of levodopa and carbidopa
03/11/2003US6531151 Tablet, powder or granule of paracetamol or diclofenac and at least one of hydroxypropylmethylcellulose, hydroxypropyl cellulose containing a minimum of 50% of substitution by hydroxypropoxy groups, and ethylcellulose as disintegrants
03/11/2003US6531149 Treating skin of a human or an animal therapeutically, by applying to said skin said hormone containing patch
03/11/2003US6531148 Treating one or both of 3,6-anhydrogalacrose and a compound having 3,6- anhydrogalactose at its reducing end under neutral to alkaline conditions; for use as food or drink additive
03/11/2003US6531143 α-hydroxy fatty acid derivatives and external compositions containing the same
03/11/2003US6531140 Anti-irritant compositions containing a cyclic nucleotide
1 ... 5540 5541 5542 5543 5544 5545 5546 5547 5548 5549 5550 5551 5552 5553 5554 5555 5556 5557 5558 5559 5560 ... 7860